Ovarian cancer survivor Susan Leighton reports on her experience at the American Association of Cancer Researchers meeting, which took place in April 2013. For the second year in a row … Continued
Earlier this month at the annual meeting of the American Academy of Cancer Research, OCRF grantee Joyce Liu, MD, MPH presented research showing that 20% of women with platinum-resistant ovarian … Continued
In a small study presented at the annual meeting of the American Association of Cancer Research earlier this month, researchers from the University of Pennsylvania reported success with a new … Continued
Women who had surgery to treat their endometriosis also lowered their risk of developing ovarian cancer. A study of approximately 600 Swedish women found that those who either had one … Continued
In a new study of over 47,000 women with ovarian cancer, researchers found disparities in the quality of ovarian cancer care and survival according to race and socioeconomic status. Not … Continued
A study of 231 cancer patients found that the use of duloxetine (Cymbalta) reduced chemotherapy induce peripheral neuropathy. Patients either recieved Cymbalta or a placebo; in the Cymbalta arm, 59% … Continued
According to research published in March 6 in the journal Nature, researchers have discovered a possible origin of epithelial ovarian cancer. The origin of ovarian cancer is unclear, making the development … Continued
On Tuesday, April 2, the U.S. Preventive Services Task Force (USPSTF) released its draft recommendation statement on Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer. The USPSTF recommends … Continued
Research published today in the Journal of the American Medical Association showed that the depression and anxiety drug duloxetine effectively treated painful chemotherapy-induced peripheral neuropathy. Chemotherapy-induced peripheral neuropathy occurs in … Continued
At this year’s Society of Gynecologic Oncology (SGO) Annual Meeting, numerous presentations and posters explored issues related to ovarian cancer, some of which are summarized below. This year’s SGO Annual … Continued
Dave Brown is walking for 9 months and nearly 3,000 miles to raise awareness and support.
Ovarian cancer survivor Peg Ford first heard about our Survivors Teaching Students: Saving Women’s Lives® (STS) program while searching for a support group in her hometown of San Diego, California. … Continued
Get email updates about research news, action alerts, and ways to join the fight.
